Literature DB >> 29367210

CD8+ T Cells Lack Local Signals To Produce IFN-γ in the Skin during Leishmania Infection.

Fernanda O Novais1, Andrea C Wong2, Daniel O Villareal3, Daniel P Beiting2, Phillip Scott1.   

Abstract

Resolution of leishmaniasis depends upon parasite control and limiting inflammation. CD4+ Th1 cells are required to control parasites, whereas CD8+ T cells play a dual role: they promote Th1 cell differentiation but can also increase inflammation at the site of infection as a consequence of cytolysis. Although CD8+ T cells taken from leishmanial lesions are cytolytic, in this study, we showed that only a few CD8+ T cells produced IFN-γ. Correspondingly, only low levels of IL-12 and/or IL-12 mRNA were present in lesions from infected mice, as well as patients. Addition of IL-12 increased IFN-γ production by CD8+ T cells isolated from leishmanial lesions, suggesting that a lack of IL-12 at the site of infection limits IFN-γ production by CD8+ T cells. To determine whether CD8+ T cells could promote resistance in vivo if IL-12 was present, we administered IL-12 to Leishmania-infected RAG mice reconstituted with CD8+ T cells. IL-12 treatment increased the ability of CD8+ T cells to make IFN-γ, but CD8+ T cells still failed to control the parasites. Furthermore, despite the ability of CD8+ T cells to promote immunity to secondary infections, we also found that CD8+ T cells from immune mice were unable to control Leishmania in RAG mice. Taken together, these results indicate that lesional CD8+ T cells fail to make IFN-γ because of a deficit in IL-12 but that, even with IL-12, CD8+ T cells are unable to control Leishmania in the absence of CD4+ T cells.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29367210      PMCID: PMC6178231          DOI: 10.4049/jimmunol.1701597

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.

Authors:  Daniela R Faria; Kenneth J Gollob; José Barbosa; Albert Schriefer; Paulo R L Machado; Hélio Lessa; Lucas P Carvalho; Marco Aurélio Romano-Silva; Amélia R de Jesus; Edgar M Carvalho; Walderez O Dutra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation.

Authors:  G F Späth; S M Beverley
Journal:  Exp Parasitol       Date:  2001-10       Impact factor: 2.011

3.  CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Authors:  Yasmine Belkaid; Esther Von Stebut; Susana Mendez; Rosalia Lira; Elisabet Caler; Sylvie Bertholet; Mark C Udey; David Sacks
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

4.  Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.

Authors:  P M Gorak; C R Engwerda; P M Kaye
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

5.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

6.  The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis.

Authors:  C S Constantinescu; B D Hondowicz; M M Elloso; M Wysocka; G Trinchieri; P Scott
Journal:  Eur J Immunol       Date:  1998-07       Impact factor: 5.532

7.  Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.

Authors:  Asha Jayakumar; Robyn Widenmaier; Xiaojing Ma; Mary Ann McDowell
Journal:  J Parasitol       Date:  2008-02       Impact factor: 1.276

8.  Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology.

Authors:  Fernanda O Novais; Lucas P Carvalho; Sara Passos; David S Roos; Edgar M Carvalho; Phillip Scott; Daniel P Beiting
Journal:  J Invest Dermatol       Date:  2014-07-18       Impact factor: 8.551

9.  Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.

Authors:  E von Stebut; Y Belkaid; T Jakob; D L Sacks; M C Udey
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

10.  Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis.

Authors:  Fernanda O Novais; Lucas P Carvalho; Joel W Graff; Daniel P Beiting; Gordon Ruthel; David S Roos; Michael R Betts; Michael H Goldschmidt; Mary E Wilson; Camila I de Oliveira; Phillip Scott
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

View more
  10 in total

Review 1.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

Review 2.  Post kala-azar dermal leishmaniasis: A threat to elimination program.

Authors:  Mallikarjuna Rao Gedda; Bhawana Singh; Dhiraj Kumar; Abhishek Kumar Singh; Prasoon Madhukar; Shreya Upadhyay; Om Prakash Singh; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2020-07-02

Review 3.  The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis.

Authors:  Fatima Conceição-Silva; Jessica Leite-Silva; Fernanda N Morgado
Journal:  Front Microbiol       Date:  2018-06-19       Impact factor: 5.640

4.  Leishmania Lipophosphoglycan Triggers Caspase-11 and the Non-canonical Activation of the NLRP3 Inflammasome.

Authors:  Renan V H de Carvalho; Warrison A Andrade; Djalma S Lima-Junior; Marisa Dilucca; Caroline V de Oliveira; Kun Wang; Paula M Nogueira; Jeronimo N Rugani; Rodrigo P Soares; Stephen M Beverley; Feng Shao; Dario S Zamboni
Journal:  Cell Rep       Date:  2019-01-08       Impact factor: 9.423

Review 5.  Host-Directed Therapies for Cutaneous Leishmaniasis.

Authors:  Fernanda O Novais; Camila Farias Amorim; Phillip Scott
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

6.  The Comparison of the IFN-ɤ, TNF-α and IL-10 Cytokines in Healing and Non-healing Cutaneous Leishmaniasis.

Authors:  Mina Taraghian; Helena Hanif; Parisa Mousavi; Zahra Baharlooeyan Cheshmeh; Azam Samei; Abbas Abdollahi; Hossein Vazini
Journal:  Iran J Parasitol       Date:  2021 Jul-Sep       Impact factor: 1.012

7.  Tissue Damage in Human Cutaneous Leishmaniasis: Correlations Between Inflammatory Cells and Molecule Expression.

Authors:  Maíra Garcia Saldanha; Carla Pagliari; Adriano Queiroz; Paulo Roberto Lima Machado; Lucas Carvalho; Phillip Scott; Edgar M Carvalho; Sérgio Arruda
Journal:  Front Cell Infect Microbiol       Date:  2020-07-14       Impact factor: 5.293

8.  Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.

Authors:  Clarissa F Cunha; Raquel Ferraz-Nogueira; Vanessa F A Costa; Maria Inês F Pimentel; Thaize Q Chometon; Marcelo R Lyra; Armando O Schubach; Alda Maria Da-Cruz; Alvaro Luiz Bertho
Journal:  PLoS One       Date:  2020-03-23       Impact factor: 3.240

Review 9.  The activation of bystander CD8+ T cells and their roles in viral infection.

Authors:  Tae-Shin Kim; Eui-Cheol Shin
Journal:  Exp Mol Med       Date:  2019-12-11       Impact factor: 8.718

10.  Human CD8+ T Cells Release Extracellular Traps Co-Localized With Cytotoxic Vesicles That Are Associated With Lesion Progression and Severity in Human Leishmaniasis.

Authors:  Carolina Cattoni Koh; Amanda B Wardini; Millene Vieira; Livia S A Passos; Patrícia Massara Martinelli; Eula Graciele A Neves; Lis Riberido do Vale Antonelli; Daniela Faria Barbosa; Teresiama Velikkakam; Eduardo Gutseit; Gustavo B Menezes; Rodolfo Cordeiro Giunchetti; Paulo Roberto Lima Machado; Edgar M Carvalho; Kenneth J Gollob; Walderez Ornelas Dutra
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.